Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Cadila Healthcare board to consider unaudited financial result

>>

Cadila Healthcare submits disclosure

>>

Zydus receives final approval for Sirolimus Tablets

>>

Cadila Healthcare submits disclosure

>>

Cadila Healthcare submits disclosure

>>

Cadila Healthcare surges on settling patent litigation with Warner Chilcott

>>

Cadila Healthcare settles patent litigation with Warner Chilcott

>>

Cadila Healthcare surges on reporting 94% rise in Q2 consolidated net profit

>>

Cadila Healthcare strengthens on reporting 94% rise in Q2 consolidated net profit

>>

Cadila Healthcare reports 94% rise in Q2 consolidated net profit

<< < 160 161 162 ...168 > >>